Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript
Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript November 13, 2023 Astria Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $-0.51. Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode. [Operator Instructions] As a […]
Andrea Matthews David Shaw Quant Noah Clauser Christopher Morabito Andrew Komjathy Chief Business Officer
Source: yahoo.com